Pharma Facing Growing Risks From Geopolitics, Industry Leaders Warn

US-China
Geopolitics, especially the US-China relationship, are a growing risk for pharma, Biogen CEO Chris Viehbacher said. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Pink Sheet